Gene · 406921
Papers4,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 4,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular vesicle-derived miR-144 as a novel mechanism for chronic intermittent hypoxia-induced endothelial dysfunction. | Theranostics | 2022 | 35673562 | PubTator, text mining | PubMed |
| The role of YAP1 in liver cancer stem cells: proven and potential mechanisms. | Biomark Res | 2022 | 35672802 | PubTator, text mining | PubMed |
| Tangled quest of post-COVID-19 infection-caused neuropathology and what 3P nano-bio-medicine can solve? | EPMA J | 2022 | 35668839 | PubTator, text mining | PubMed |
| TMEM16A as a potential treatment target for head and neck cancer. | J Exp Clin Cancer Res | 2022 | 35668455 | PubTator, text mining | PubMed |
| MiR-132-3p inhibits proliferation, invasion and migration of colorectal cancer cells via down-regulating FOXP2 expression. | Acta Biochim Pol | 2022 | 35667086 | PubTator, text mining | PubMed |
| MicroRNA Alterations in Chronic Traumatic Encephalopathy and Amyotrophic Lateral Sclerosis. | Front Neurosci | 2022 | 35663558 | PubTator, text mining | PubMed |
| Quercetin Inhibits Tumorigenesis of Colorectal Cancer Through Downregulation of hsa_circ_0006990. | Front Pharmacol | 2022 | 35662705 | PubTator, text mining | PubMed |
| A new age in understanding adult hippocampal neurogenesis in Alzheimer's disease. | Neural Regen Res | 2022 | 35662190 | PubTator, text mining | PubMed |
| MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer. | Biomark Res | 2022 | 35659780 | PubTator, text mining | PubMed |
| Expression relationship and significance of NEAT1 and miR-27a-3p in serum and cerebrospinal fluid of patients with Alzheimer's disease. | BMC Neurol | 2022 | 35659599 | PubTator, text mining | PubMed |
| Mechanistic insights gained from cell and molecular analysis of the neuroprotective potential of bioactive natural compounds in an immortalized hippocampal cell line. | PLoS One | 2022 | 35657963 | PubTator, text mining | PubMed |
| MicroRNA inhibition using antimiRs in acute human brain tissue sections. | Epilepsia | 2022 | 35656590 | PubTator, text mining | PubMed |
| Novel targets in rectal cancer by considering lncRNA-miRNA-mRNA network in response to Lactobacillus acidophilus consumption: a randomized clinical trial. | Sci Rep | 2022 | 35654932 | PubTator, text mining | PubMed |
| Circular RNA: An emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines. | J Control Release | 2022 | 35649485 | PubTator, text mining | PubMed |
| Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction. | Front Cardiovasc Med | 2022 | 35647075 | PubTator, text mining | PubMed |
| A "cell-free treatment" for tendon injuries: adipose stem cell-derived exosomes. | Eur J Med Res | 2022 | 35643543 | PubTator, text mining | PubMed |
| Menopausal Transition: Prospective Study of Estrogen Status, Circulating MicroRNAs, and Biomarkers of Bone Metabolism. | Front Endocrinol (Lausanne) | 2022 | 35634507 | PubTator, text mining | PubMed |
| The Regulatory Role of MicroRNAs on Phagocytes: A Potential Therapeutic Target for Chronic Diseases. | Front Immunol | 2022 | 35634335 | PubTator, text mining | PubMed |
| Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases. | J Pers Med | 2022 | 35629192 | PubTator, text mining | PubMed |
| Histone Modifications and Non-Coding RNAs: Mutual Epigenetic Regulation and Role in Pathogenesis. | Int J Mol Sci | 2022 | 35628612 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406921/papers?page=50